← Every company
Gilead Sciences, Inc Lobbying
What Gilead Sciences, Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
GILD on carbonthat →Disclosed spend
$6.5M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidPharmacyBudget/AppropriationsTaxation/Internal Revenue CodeTrade (domestic/foreign)
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | GILEAD SCIENCES, INC.Trade (domestic/foreign)Health Issues | $3.2M |
| 20262nd Quarter (Apr 1 - June 30) | GILEAD SCIENCES, INC.Copyright/Patent/TrademarkBudget/Appropriations | $1.6M |
| 20261st Quarter (Jan 1 - Mar 31) | MILLER STRATEGIES, LLCHealth IssuesBudget/Appropriations | $150K |
| 20262nd Quarter (Apr 1 - June 30) | MILLER STRATEGIES, LLCHealth IssuesBudget/Appropriations | $150K |
| 20261st Quarter (Jan 1 - Mar 31) | FORBES-TATEHealth Issues | $90K |
| 20262nd Quarter (Apr 1 - June 30) | THE DUBERSTEIN GROUP INC.Health Issues | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | THE DUBERSTEIN GROUP INC.Health Issues | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | FARRAGUT PARTNERS LLPHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | FARRAGUT PARTNERS LLPHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health Issues | $75K |
| 20262nd Quarter (Apr 1 - June 30) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health Issues | $75K |
| 20262nd Quarter (Apr 1 - June 30) | CAPITOL TAX PARTNERS, LLPTaxation/Internal Revenue Code | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | THE MCMANUS GROUPMedicare/MedicaidHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | THE MCMANUS GROUPMedicare/MedicaidHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | W STRATEGIES, LLCMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPMedicare/MedicaidBudget/Appropriations | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | W STRATEGIES, LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL TAX PARTNERS, LLPTaxation/Internal Revenue Code | $60K |
| 20262nd Quarter (Apr 1 - June 30) | EMPIRE CONSULTING GROUPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | EMPIRE CONSULTING GROUPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on GILD
Company overviewEverything on GILD in one place, with the price.SEC filingsWhat GILD's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat GILD's own officers and directors buy and sell.Planned salesSales GILD insiders have filed notice of.Who owns itEvery manager reporting a position in GILD.Funds holding itWhich funds and ETFs hold GILD, and how big a bet.Who lobbies for itThe lobbyists on GILD's account, and who they worked for.Federal contractsWhat federal agencies pay GILD.PatentsWhat GILD is filing at the patent office.